Grants & Awards 2012

September 2012 

Orlando Gutierrez, MD
Impact of disordered mineral metabolism on stroke and cognitive impairments
National Institutes of Health
New
$1,244,853
09/01/12 - 07/31/17

Ashita Tolwani, M.D.
CRRT 2012
NxStage
New
$3,000
09/1/12 - 09/30/12

Ashita Tolwani, M.D.
CRRT 2012
Gambro
New
$18,000
09/1/12 - 09/30/12


August 2012

Lionel Clement, Ph.D.
Investigation of Nephrotic Syndrome 
National Institutes of Health
New
$761,455
08/01/12 - 06/30/17 


July 2012

Edgar Jaimes, M.D.
VA IPA
VA
New
$70,895
07/01/12 - 06/30/14 


June 2012

Orlando Gutierrez, MD
Phosphorus-based Food Additives on Mineral Metabolism and Cardiovascular Health 
National Institutes of Health
New
$549,375
06/20/12 - 05/31/15


May 2012

Anupam Agarwal, MD
Examination of the effects of CXA-10 on serum creatinine in a rat model of acute kidney injury.
Complexa
New
$55,763
05/01/12 - 04/30/14

Edgar Jaimes, MD
VA IPA
VA
New
$60,439
05/01/12 - 06/01/13


April 2012

Anupam Agarwal, MD
NRTC Seminar Series Oxidative Stress Chronic Kidney Disease and Artherosclerosis
Genzyme
New
$3,300
04/16/12 - 04/16/12

Orlando Gutierrez, MD
4th Rostand Vitamin D Receptor Activation Symposium and Festschrift
Abbott
New
$4,500
04/13/12 - 04/13/12 

Orlando Gutierrez, MD
4th Rostand Vitamin D Receptor Activation Symposium and Festschrift
Genzyme
New
$4,000
04/13/12 - 04/13/12


March 2012

Dana Rizk MD
A Multiple-Dose, Open Label, Pharmacokinetic and Pharmacodynamic Study of Bardoxolone Methyl in Subjects with Chronic Kidney Disease and Type 2 Diabetes
Reata Pharmaceuticals
New
$86,572
03/13/2012 - 03/12/2014

David Warnock, MD
Annual Fabry Family Meeting
New
$4,700
03/10/12 - 03/31/12


February 2012

Zipporah Krishnasami, MD
Sister Renal Center Program 2012
International Society of Nephrology
New
$1,500 02/21/12 - 12/31/12

January 2012

Michael Allon, M.D.
Hemodialysis Fistula Maturation Consortium Clinical Sige
NIH/Subcontract with Cleveland Clinic
New
$126,416 01/01/12 - 05/31/12

Wenguang Feng, Ph.D.
Nicotine and Hypertensive Chronic Kidney Disease
MACAU Hypertension Alliance
New
$33,000 01/01/12 - 12/31/12

David G. Warnock, M.D.
An Open-Label, Phase 2A Study to Investigate Drug-Drug Interactions Between AT1001 (Migalastat hydrochloride) and Agalsidase Beta in Subjetcs with Fabry Disease
Amicus Therapeutics
New
$79,695 01/18/12 - 07/31/12